Iridia, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2001, the company has established itself as a pioneer in developing advanced diagnostic solutions and therapeutic products that enhance patient care and streamline healthcare processes. Iridia's core offerings include cutting-edge molecular diagnostics and personalised medicine solutions, distinguished by their accuracy and rapid turnaround times. The company has achieved notable milestones, including several FDA approvals and partnerships with major healthcare institutions, solidifying its position as a trusted name in the industry. With a commitment to innovation and quality, Iridia continues to drive advancements in healthcare, making a meaningful impact on patient outcomes worldwide.
How does Iridia, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Iridia, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Iridia, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established specific reduction targets or initiatives, nor does it participate in recognised climate pledges such as the Science Based Targets initiative (SBTi). In the absence of reported emissions or commitments, it is unclear how Iridia, Inc. aligns with industry standards for climate action. The company may need to develop and disclose its climate strategy to enhance transparency and accountability in its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Iridia, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

